'For the quarter ending March 2024, consolidated net sales (including other operating income) of Shalby has increased 22.74% to Rs 244.23 crore compared to quarter ended March 2023.  Sales of Health care services segment has gone up 20.55% to Rs 218.42 crore (accounting for 89.43% of total sales).  Sales of Manufacturing of implants segment has gone up 45.08% to Rs 25.81 crore (accounting for 10.57% of total sales).  

Profit before interest, tax and other unallocable items (PBIT) has jumped 13.51% to Rs 21.78 crore.  PBIT of Health care services segment rose 23.14% to Rs 27.96 crore (accounting for 128.35% of total PBIT).  PBIT of Manufacturing of implants segment fell 75.73% to Rs -6.18 crore (accounting for -28.35% of total PBIT).  

PBIT margin of Health care services segment rose from 12.53% to 12.80%.  PBIT margin of Manufacturing of implants segment fell from negative 19.75% to negative 23.92%.&nb...

• 

  (27-Apr-2025)

  Macrotech Developers

  Sales up 5%, net up 39%
• 

  (27-Apr-2025)

  Avantel

  Net down 50% on lower OPM
• 

  (26-Apr-2025)

  IDFC First Bank

  Fresh slippages and credit cost remains elevated
• 

  (26-Apr-2025)

  Cholamandalam Investment & Finance Company

  AUM rises 30%